Acacia Research Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research through its CombiMatrix group division.
The following report cites that the company uses animals for testing drugs and clinical research.
“Through the CombiMatrix group’s minority ownership of Leuchemix, Inc., we have access to proprietary compounds that have been shown to be cytotoxic towards certain cancers in-vitro and in vivo. Leuchemix, Inc. has access to a bank of over 150 primary leukemia specimens and a panel of 15 leukemia and lymphoma cell lines as well as several xenogenic animal model systems.” (Page 16) Read the full document.
Acacia Research Corp. engages in the acquisition, development, and patents technologies through its subsidiaries. Its operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, if necessary, with the enforcement against unauthorized users of their patented technologies. The company was founded on January 25, 1993 and is headquartered in Newport Beach, CA. [Source: MarketWatch]
Company Website: http://acaciaresearch.com